financetom
Business
financetom
/
Business
/
Vishay Unveils High-Precision RGBIR Sensor For Smarter Automotive Displays
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vishay Unveils High-Precision RGBIR Sensor For Smarter Automotive Displays
Apr 3, 2025 6:50 AM

Vishay Intertechnology, Inc. ( VSH ) shares are trading lower in the premarket session on Thursday.

Yesterday, the firm introduced an innovation with the launch of AEC-Q100 qualified RGBIR color sensor.

The new sensor, named VEML6046X00, is designed for high-accuracy color temperature calculations, enabling precise white point balancing for automotive displays.

This advanced sensor features a sensitive photodiode, a low-noise amplifier, and a 16-bit ADC, all packed into a compact 2.67 mm by 2.45 mm surface-mount package with a slim 0.6 mm profile.

One of the standout features of the VEML6046X00 is its ability to handle separate red, green, blue, and infrared channels, which ensures accurate measurements even in varying lighting conditions.

Also Read: Jeff Bezos’ Amazon To Launch Kuiper Internet Satellites On April 9, Taking On Elon Musk’s Starlink

Its green channel mimics the spectral sensitivity of the human eye for realistic color detection, while the IR channel stabilizes output across diverse light sources.

With an ambient light range of 0 lx to 176 klx, the sensor remains stable and does not saturate under direct daylight.

The sensor’s versatility makes it suitable for a range of automotive applications, including display backlight controls, infotainment systems, rearview mirror dimming, and interior lighting. It operates across a wide temperature range up to +110°C and features an I²C communication interface for ease of integration.

Samples of the VEML6046X00 are available now, with production quantities set for a 16-week lead time.

According to Benzinga Pro, VSH stock has lost over 28% in the past year.

Price Action: VSH shares are trading lower by 4.77% to $15.17 premarket at last check Thursday.

Read Next:

 Trump’s ‘Reciprocal Tariff’ Math: A Masterclass In Economic Absurdity

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved